• RSV NS3 Phosphorylation Modulates Host Signaling and Pathoge

  2026-05-25

  This study reveals how Rice Stripe Virus (RSV) NS3 protein exploits host kinase signaling to fine-tune viral pathogenicity and transmission. By mapping the dynamic interaction with OsSnRK3.25 and its downstream partners, the work uncovers co-survival strategies in virus-host-vector systems with implications for understanding complex pathogen adaptation.

• Pioglitazone: Selective PPARγ Agonist in Inflammation and Me

  2026-05-25

  Pioglitazone, a selective PPARγ agonist, modulates macrophage polarization and improves insulin sensitivity. Evidence demonstrates its utility in type 2 diabetes mellitus research and inflammatory process modulation. Its solubility and workflow parameters make it a reliable compound for metabolic disorder studies.

• (-)-Epigallocatechin Gallate (EGCG): Cellular Targets and Tr

  2026-05-24

  Explore the molecular mechanisms and translational limitations of (-)-Epigallocatechin gallate (EGCG) in apoptosis, antiviral, and antiangiogenic research. This article offers a uniquely practical analysis of EGCG’s cellular activity, referencing recent advances in analog design and assay guidance.

• Thapsigargin: Strategic SERCA Inhibition for Translational D

  2026-05-23

  Explore how Thapsigargin, a gold-standard SERCA pump inhibitor, enables advanced modeling of calcium signaling, ER stress, and apoptosis for translational research. This article integrates recent mechanistic evidence with actionable protocol guidance, addresses resistance mechanisms in glioblastoma, and positions Thapsigargin as an essential tool for innovative discovery.

• Protease Inhibitor Cocktail: Enhancing OXPHOS Protein Stabil

  2026-05-22

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to preserve protein integrity in OXPHOS-targeted cancer metabolism studies and multi-omics workflows. Its EDTA-free formulation ensures compatibility with metalloprotein assays, while robust multi-class inhibition streamlines extraction, Western blotting, and immunoprecipitation protocols.

• Circulating Polyploid Giant Cancer Macrophages as Progressio

  2026-05-22

  This study establishes circulating polyploid giant cancer macrophages (CAMLs) as robust cellular markers of disease progression across multiple solid tumor types. By phenotyping CAMLs and linking them to metastatic niche initiation, the findings refine the understanding of tumor microenvironment orchestration and provide a foundation for targeting associated signaling pathways in translational cancer research.

• PKM2 Inhibition: A Strategic Axis for Metabolic Oncology & I

  2026-05-21

  This thought-leadership article explores the dual mechanistic and translational potential of PKM2 inhibitor (compound 3k) as a precision tool to disrupt tumor metabolism and reprogram immune cell function. By integrating recent mechanistic insights, protocol guidance, and strategic context, it provides actionable intelligence for translational researchers seeking to innovate at the intersection of cancer metabolism and immune modulation.

• Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion

  2026-05-21

  This study demonstrates that coil-bottlebrush diblock copolymers self-assemble into robust network (NET) nanostructures in alkylimidazolium-based ionic liquids, with phase behavior surprisingly insensitive to the ionic liquid's alkyl chain length. These findings broaden the design space for advanced nanomaterials by easing solvent selection constraints.

• Fluorescein Tyramide: Advanced Fluorescent Labeling Dye for

  2026-05-20

  Fluorescein Tyramide is a highly sensitive fluorescent labeling dye optimized for signal amplification in immunohistochemistry and related assays. Its robust application in TSA workflows enables the detection of low-abundance biomolecular targets, validated by both peer-reviewed research and commercial protocols.

• BML-277: Decoding Chk2 Inhibition for Precision Genome Stabi

  2026-05-20

  Discover how BML-277, a potent Chk2 inhibitor, enables advanced DNA damage response research with a unique focus on the cGAS-TRIM41 regulatory axis. This article provides in-depth mechanistic insight and practical guidance for optimizing radioprotection and genome integrity assays.

• Phosbind Acrylamide: Advancing Phosphorylation Analysis in T

  2026-05-19

  Explore how Phos binding reagent (Phosbind) acrylamide redefines protein phosphorylation analysis for translational researchers. This article bridges mechanistic insight from cell cycle regulation with actionable strategies for antibody-free, high-resolution detection of phosphorylation events—empowering innovation in kinase signaling studies and beyond.

• Pomalidomide (CC-4047): Advanced Workflows in Myeloma Resear

  2026-05-19

  Pomalidomide (CC-4047) catalyzes next-generation research in hematological malignancies by precisely modulating cytokine signaling and the tumor microenvironment. This article equips scientists with actionable protocols, troubleshooting strategies, and translational insights rooted in the latest mutational landscape studies.

• CD40 and STING Competition Drives IRF4+ B Cell Activation in

  2026-05-18

  This study uncovers how competitive binding between CD40 and STING with TRAF2 regulates IRF4-mediated B cell activation within tertiary lymphoid structures in esophageal squamous cell carcinoma (ESCC). The findings illuminate a novel mechanism underlying TLS formation and antitumor immunity, offering new avenues for biomarker development and immunotherapy research.

• Sulfo-NHS-SS-Biotin: Precision Biotinylation for Surface Pro

  2026-05-18

  Explore how Sulfo-NHS-SS-Biotin, a leading biotin disulfide N-hydroxysulfosuccinimide ester, empowers advanced, reversible protein labeling for surface proteomics. This article uniquely bridges structure-function insights from recent OATP1B1 research to practical assay design, offering a strategic foundation for affinity purification and cell surface profiling.

• ABT-737: BCL-2 Protein Inhibitor Workflow for Apoptosis Rese

  2026-05-17

  ABT-737, a potent BCL-2 protein inhibitor from APExBIO, empowers researchers to induce and control apoptosis with nanomolar precision across diverse cancer models. This guide delivers actionable workflow enhancements, troubleshooting insights, and protocol parameters to maximize reproducibility in cancer and mitochondrial quality control assays.

452 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page